CUMULUS ONCOLOGY LIMITED
Company number SC581311 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£5,459,619
Balance sheet as at 2023-05-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-11-13
- Employees
- 10 (2023 accounts · was 8 in 2022)
- Registered office
- 61 Dublin Street, Edinburgh, Midlothian, Scotland, EH3 6NL
- Postcode
- EH3 6NL
- Capital
- 643 GBP
- Accounts category
- Small
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-11-12
- Next due by
- 2026-11-26
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
- 72190 Other research and experimental development on natural sciences and engineering
Officers 7 current · 10 resigned
Group structure 2 subsidiaries
-
MODULUS ONCOLOGY LIMITED Dissolved
From persons-with-significant-control filings on the public register.
Contact details
- Website
- cumulusoncology.com
Finding assets, creating spin-outs, commercialising cancer therapies
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 7-11 MELVILLE STREET EDINBURGH, EH3 7PE, UNITED KINGDOM | 2020-02-20 |
Among its peers
Top 10%
by shareholders' funds, of 68 similar companies in EH
Among the biggest employers among its local peers (10 staff).
Trading since 2017.
No.4 of the largest research and experimental development on biotechnology companies in Edinburgh →
Competitors Edinburgh
This company ranks 4 among research and experimental development on biotechnology in Edinburgh.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.